SERB PHARMACEUTICALS Trademark
SERB PHARMACEUTICALS is a USPTO trademark filed by SERB. Status: Registered.
Prosecution Summary
Trademark Summary
The mark SERB PHARMACEUTICALS is a stylized design featuring purple wording with "SERB" above "PHARMACEUTICALS" alongside a multicolored purple donut-shaped circle, disclaiming "PHARMACEUTICALS," and covers chemicals for scientific use (class 001), pharmaceutical preparations for poisonings, snake bites, radiation exposure and more (class 005), surgical and medical apparatus (class 010), medical research (class 042), and medical/veterinary services (class 044). It is registered on the Principal Register since July 15, 2025, expiring January 15, 2034, based on international registration WO1795872 with priority from July 24, 2023. Owner is Luxembourg-based SERB, a Société à responsabilité limitée.
Recent Activity
Filed under Section 66A
Trademark Facts
| Mark | SERB PHARMACEUTICALS |
|---|---|
| Serial Number | 79398370 |
| Registration Number | 7862493 |
| Status | Registered |
| Filing Date | 2024-01-15 |
| Registration Date | 2025-07-15 |
| Mark Type | Combined |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 010 (Medical Devices), 042 (Software & IT), 044 (Medical Services) |
| Owner | SERB |
| Attorney of Record | Sherry L. Rollo |
| Prosecution Events | 37 |
| Latest Event | FINO on 2026-02-26 |
Goods & Services
Pharmaceutical preparations, medicines and substances, namely, pharmaceutical preparations for treating poisonings, overdoses of any type, allergies, snake bites, exposure to nuclear radiation, infections, tumors, heart diseases, blood diseases, skin diseases, gastric diseases, liver diseases, neurological diseases, ophthalmological diseases, lung diseases, rheumatological diseases, rare ocular diseases; Pharmaceutical preparations for the treatment of snake bite venom; Pharmaceutical preparations for the treatment of digoxin toxicity and overdose; Pharmaceutical preparations for the treatment of methotrexate toxicity and overdose; Pharmaceutical preparations, namely, potassium iodide, for the treatment of exposure to nuclear radiation; Pharmaceutical preparations for the treatment of cyanide poisoning; Antidotes; veterinary preparations, medicines and substances, namely, veterinary preparations of snake bite venom to treat snake bites, veterinary preparations for the treatment of digoxin toxicity and overdose, veterinary preparations for the treatment of methotrexate toxicity and overdose, veterinary preparations for the treatment of cyanide poisoning; Biological preparations for medical, pharmaceutical and veterinary use, namely, biological preparations for the treatment of cancer; radioactive substances for medical use; dietetic beverages and foods adapted for medical use; nutritional supplements for medical use; diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary use; radiological contrast substances for medical use; herbal tinctures for medical use; surgical implants made of living tissue; medical and veterinary microbial media, namely, cell culture media for medical and veterinary use; cultures of microorganisms for medical or veterinary use; antibiotic preparations; dressings for medical use.; Chemical preparations for scientific use, other than for medical or veterinary use; Chemical substances for scientific use for analyses in laboratories, other than for medical or veterinary use; chemical preparations and substances with or without coloring agents for laboratory analyses, other than for medical or veterinary use; chemical preparations for scientific purposes other than for medical or veterinary use; diagnostic preparations and substances in the nature of chemicals with or without coloring agents other than for medical or veterinary use, namely, chemical diagnostic reagents for industrial purposes; chemical additives with or without coloring agents used in the composition of diagnostic preparations and substances, namely, chemical additives for use in the manufacture of pharmaceuticals; chemical reagents with or without coloring agents, other than for medical or veterinary use, namely, chemical reagents for non-medical purposes; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of snake bite venom, the treatment of digoxin toxicity and overdose, the treatment of methotrexate toxicity and overdose, the treatment of exposure to nuclear radiation and the treatment of cyanide poisoning; Medical services; medical assistance; veterinary services; consultation with respect to pharmacy, namely, pharmaceutical consultation; "PHARMACEUTICALS"; Surgical apparatus and instruments for medical, dental and veterinary use; infusion apparatus for therapeutic use; thermometers for medical use; Artificial implants, namely, implants consisting of artificial materials; stents; Dental prostheses; cardiac pacemakers; lenses in the nature of intraocular prostheses for surgical implantation; Orthopedic articles, namely, orthopedic braces for the prevention and the correction of disorders of the musculoskeletal system affecting bones, joints, muscles, tendons and nerves; x-ray apparatus for medical use; Electromagnetic medical diagnostic imaging apparatus; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic equipment, namely, diagnostic penlights for medical purposes; Medical research services; Scientific research for medical use; pharmaceutical diagnostic testing services, namely, testing of pharmaceuticals; pharmaceutical diagnostic testing services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals; Research and development of new products; assessment in scientific and technical fields provided by engineers, namely, consulting in the field of engineering; Appraisals in the fields of science and technology provided by engineers, namely, conducting scientific feasibility studies; scientific research; Technical and scientific studies, namely, conducting scientific feasibility studies